113 related articles for article (PubMed ID: 37040675)
41. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ
J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252
[TBL] [Abstract][Full Text] [Related]
42. Genome-wide profiling of micro-RNA expression in gefitinib-resistant human lung adenocarcinoma using microarray for the identification of miR-149-5p modulation.
Hu Y; Qin X; Yan D; Cao H; Zhou L; Fan F; Zang J; Ni J; Xu X; Sha H; Liu S; Yu S; Wu J; Ma R; Feng J
Tumour Biol; 2017 Mar; 39(3):1010428317691659. PubMed ID: 28345454
[TBL] [Abstract][Full Text] [Related]
43. Classification of non-small cell lung carcinoma in transthoracic needle specimens using microRNA expression profiling.
Fassina A; Cappellesso R; Fassan M
Chest; 2011 Nov; 140(5):1305-1311. PubMed ID: 21622546
[TBL] [Abstract][Full Text] [Related]
44. Research on the typical miRNA and target genes in squamous cell carcinoma and adenocarcinoma of esophagus cancer with DNA microarray.
Wang HB; Jiang ZB; Li M
Pathol Oncol Res; 2014 Apr; 20(2):245-52. PubMed ID: 24519530
[TBL] [Abstract][Full Text] [Related]
45. Distinct Patterns of mRNA and lncRNA Expression Differences Between Lung Squamous Cell Carcinoma and Adenocarcinoma.
Tian Y; Yu M; Sun L; Liu L; Wang J; Hui K; Nan Q; Nie X; Ren Y; Ren X
J Comput Biol; 2020 Jul; 27(7):1067-1078. PubMed ID: 31750732
[TBL] [Abstract][Full Text] [Related]
46. Up-Regulation of miR-21 Expression Predicate Advanced Clinicopathological Features and Poor Prognosis in Patients with Non-Small Cell Lung Cancer.
Tian L; Shan W; Zhang Y; Lv X; Li X; Wei C
Pathol Oncol Res; 2016 Jan; 22(1):161-7. PubMed ID: 26453197
[TBL] [Abstract][Full Text] [Related]
47. MicroRNA profiling in lung cancer reveals new molecular markers for diagnosis.
Solomides CC; Evans BJ; Navenot JM; Vadigepalli R; Peiper SC; Wang ZX
Acta Cytol; 2012; 56(6):645-54. PubMed ID: 23207443
[TBL] [Abstract][Full Text] [Related]
48. ERCC6L is a biomarker and therapeutic target for non-small cell lung adenocarcinoma.
Hou G; Lu Z; Bi Y; Deng J; Yang X
Med Oncol; 2022 Feb; 39(5):51. PubMed ID: 35150321
[TBL] [Abstract][Full Text] [Related]
49. [Study on Genetype in Lung Squamous Carcinoma by High-throughput of
Transcriptome Sequence].
Xiong Y; Li M; Zhang P; Zhang L; Yang Y
Zhongguo Fei Ai Za Zhi; 2017 Nov; 20(11):727-731. PubMed ID: 29167000
[TBL] [Abstract][Full Text] [Related]
50. miR-20a regulates expression of the iron exporter ferroportin in lung cancer.
Babu KR; Muckenthaler MU
J Mol Med (Berl); 2016 Mar; 94(3):347-59. PubMed ID: 26560875
[TBL] [Abstract][Full Text] [Related]
51. Bcl-xL silencing induces alterations in hsa-miR-608 expression and subsequent cell death in A549 and SK-LU1 human lung adenocarcinoma cells.
Othman N; In LL; Harikrishna JA; Hasima N
PLoS One; 2013; 8(12):e81735. PubMed ID: 24339958
[TBL] [Abstract][Full Text] [Related]
52. The genomic alterations of lung adenocarcinoma and lung squamous cell carcinoma can explain the differences of their overall survival rates.
Meng F; Zhang L; Ren Y; Ma Q
J Cell Physiol; 2019 Jul; 234(7):10918-10925. PubMed ID: 30549039
[TBL] [Abstract][Full Text] [Related]
53. MicroRNA-dependent regulation of transcription in non-small cell lung cancer.
Molina-Pinelo S; Gutiérrez G; Pastor MD; Hergueta M; Moreno-Bueno G; García-Carbonero R; Nogal A; Suárez R; Salinas A; Pozo-Rodríguez F; Lopez-Rios F; Agulló-Ortuño MT; Ferrer I; Perpiñá A; Palacios J; Carnero A; Paz-Ares L
PLoS One; 2014; 9(3):e90524. PubMed ID: 24625834
[TBL] [Abstract][Full Text] [Related]
54. A dual role for KRT81: a miR-SNP associated with recurrence in non-small-cell lung cancer and a novel marker of squamous cell lung carcinoma.
Campayo M; Navarro A; Viñolas N; Tejero R; Muñoz C; Diaz T; Marrades R; Cabanas ML; Gimferrer JM; Gascon P; Ramirez J; Monzo M
PLoS One; 2011; 6(7):e22509. PubMed ID: 21799879
[TBL] [Abstract][Full Text] [Related]
55. RNA-Seq profiling of circular RNA in human lung adenocarcinoma and squamous cell carcinoma.
Wang C; Tan S; Liu WR; Lei Q; Qiao W; Wu Y; Liu X; Cheng W; Wei YQ; Peng Y; Li W
Mol Cancer; 2019 Sep; 18(1):134. PubMed ID: 31484581
[TBL] [Abstract][Full Text] [Related]
56. MicroRNA expression differentiates histology and predicts survival of lung cancer.
Landi MT; Zhao Y; Rotunno M; Koshiol J; Liu H; Bergen AW; Rubagotti M; Goldstein AM; Linnoila I; Marincola FM; Tucker MA; Bertazzi PA; Pesatori AC; Caporaso NE; McShane LM; Wang E
Clin Cancer Res; 2010 Jan; 16(2):430-41. PubMed ID: 20068076
[TBL] [Abstract][Full Text] [Related]
57. Reply to "MiR-205 and miR-375 microRNA Assays to Distinguish Squamous Cell Carcinoma From Adenocarcinoma in Lung Cancer Biopsies".
Patnaik SK; Yendamuri S; Mallick R; Dhillon SS
J Thorac Oncol; 2015 Jun; 10(6):e53. PubMed ID: 26001155
[No Abstract] [Full Text] [Related]
58. Exploring and comparing of the gene expression and methylation differences between lung adenocarcinoma and squamous cell carcinoma.
Yang Y; Wang M; Liu B
J Cell Physiol; 2019 Apr; 234(4):4454-4459. PubMed ID: 30317601
[TBL] [Abstract][Full Text] [Related]
59. Non-overlapping and non-cell-type-specific gene expression signatures predict lung cancer survival.
Sun Z; Wigle DA; Yang P
J Clin Oncol; 2008 Feb; 26(6):877-83. PubMed ID: 18281660
[TBL] [Abstract][Full Text] [Related]
60. Mutations in genes connected with the TCF7L2 transcription factor are associated with a poor prognosis in non-small cell lung cancer.
Rice SJ; Liu X; Hyland V; Liu Z; Belani CP
Lung Cancer; 2020 Mar; 141():97-100. PubMed ID: 31986371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
